HISTOLOGICAL FEATURES OF ACUTE PANCREATIC ALLOGRAFT-REJECTION AFTER PANCREATICODUODENAL TRANSPLANTATION IN THE RAT

被引:6
|
作者
DIETZE, O
KONIGSRAINER, A
HABRINGER, C
KRAUSLER, R
KLIMA, G
MARGREITER, R
机构
[1] Department of Pathology, School of Medicine, University of Innsbruck, Innsbruck, A-6020
[2] Department of Transplantation Surgery, School of Medicine, University of Innsbruck, Innsbruck, A-6020
[3] Department of Histology, School of Medicine, University of Innsbruck, Innsbruck, A-6020
关键词
PANCREAS TRANSPLANTATION; RAT; REJECTION; REJECTION HISTOLOGY; PANCREATIC DUCTS; IN EXPERIMENTAL REJECTION;
D O I
10.1007/BF00649107
中图分类号
R61 [外科手术学];
学科分类号
摘要
For characterization of histopathological changes during pancreas graft rejection, pancreaticoduodenal transplants were performed in three groups: (1) Brown Norway into diabetic Lewis rats without immunosuppression, (2) Brown Norway into diabetic Lewis rats with cyclosporin A, and (3) Lewis into Lewis rats. Diffuse inflammatory infiltration of the acini by mononuclear cells indicated the onset of rejection (stage I). Shortly after acinar infiltration, damage to small and large interlobular excretion ducts occurred. This took the form of florid circumferential inflammation and vacuolar degeneration of epithelium similar to the bile duct damage seen in primary biliary cirrhosis, graft-versus-host disease, and liver allograft rejection (stage II). Thereafter, endothelialitis and destruction of islets were evident, consistent with a more advanced and irreversible stage of rejection (stage III). Acinar inflammation and moderate duct lesions were not prevented by immunosuppression but were delayed. Nonetheless, severe vascular changes and loss of islets were avoided. We conclude that duct lesions are a reliable criterion for pancreas allograft rejection. They are more sensitive than vascular changes and more specific than cellular infiltration of acinar tissue, which may also occur in infection.
引用
下载
收藏
页码:221 / 226
页数:6
相关论文
共 50 条
  • [41] USE OF ATG FOR REVERSAL OF ACUTE ALLOGRAFT-REJECTION
    HARDY, MA
    APPEL, G
    NOWYGROD, R
    EUROPEAN SURGICAL RESEARCH, 1980, 12 : 73 - 74
  • [42] DIAGNOSIS AND TREATMENT OF ACUTE CARDIAC ALLOGRAFT-REJECTION
    OYER, PE
    STINSON, EB
    BIEBER, CP
    REITZ, BA
    RANEY, AA
    BAUMGARTNER, WA
    SHUMWAY, NE
    TRANSPLANTATION PROCEEDINGS, 1979, 11 (01) : 296 - 303
  • [43] USE OF ATG FOR REVERSAL OF ACUTE ALLOGRAFT-REJECTION
    NOWYGROD, R
    APPEL, G
    HARDY, MA
    TRANSPLANTATION PROCEEDINGS, 1981, 13 (01) : 469 - 472
  • [44] ELECTROCARDIOGRAPHIC DETECTION OF ACUTE CARDIAC ALLOGRAFT-REJECTION
    VOLKER, H
    SIGMUND, M
    VOGT, L
    SILNY, J
    KEMNITZ, J
    KIRKPATRICK, CJ
    EFFERT, S
    HANRATH, P
    ZEITSCHRIFT FUR KARDIOLOGIE, 1992, 81 (08): : 418 - 422
  • [45] CYCLOSPORINE IN THE TREATMENT OF ACUTE KIDNEY ALLOGRAFT-REJECTION
    LAMPERI, S
    CAROZZI, S
    NOCERA, A
    MANCA, F
    TRANSPLANTATION PROCEEDINGS, 1985, 17 : 65 - 66
  • [46] ACUTE PHASE PROTEINS AND LIVER ALLOGRAFT-REJECTION
    MAURY, CPJ
    TEPPO, AM
    HOCKERSTEDT, K
    LIVER, 1988, 8 (02): : 75 - 79
  • [47] THE USE OF CYCLOSPORINE IN TREATING ACUTE ALLOGRAFT-REJECTION
    DICKERMAN, RM
    VERGNEMARINI, P
    LONG, DL
    NESSER, DA
    VELEZ, RL
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 78 - 80
  • [48] SEVERE GLOMERULOPATHY IN EARLY ACUTE ALLOGRAFT-REJECTION
    VERANI, RR
    FLOYD, M
    KAHAN, B
    LABORATORY INVESTIGATION, 1980, 42 (01) : 157 - 157
  • [49] ACTIVATION MARKERS IN ACUTE LIVER ALLOGRAFT-REJECTION
    LAUTENSCHLAGER, I
    HOCKERSTEDT, K
    HAYRY, P
    TRANSPLANTATION PROCEEDINGS, 1988, 20 (04) : 646 - 647
  • [50] FREE-RADICALS IN PANCREATIC AND CARDIAC ALLOGRAFT-REJECTION
    ROZA, AM
    PIEPER, G
    MOOREHILTON, G
    JOHNSON, CP
    ADAMS, MB
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (02) : 544 - 545